Table 2

Distribution of patient and treatment characteristics in relation to recurrence of achalasia

CharacteristicnRecurrence (n)5-Year risk of recurrence (SE)10-Year risk of recurrence (SE)HR (95% CI)p Value
Sex
 Male161520.27±0.040.33±0.041.00.93
 Female175590.29±0.040.37±0.041.02 (0.7 to 1.5)
Age (years) at onset
 <2131230.64±0.90.72±0.091.0<0.001
 21–4091420.31±0.50.38±0.060.4 (0.3 to 0.7)
 40–5046110.17±0.60.33±0.100.3 (0.1 to 0.5)
 >50168350.21±0.30.24±0.040.2 (0.1 to 0.4)
Type of achalasia
 Classic222/288790.28±0.030.36±0.041.8 (1.0 to 3.2)0.032
 Vigorous66/288150.18±0.050.21±0.061.0
Timed barium oesophagram
 Oesophagus dilation yes275/326870.27±0.030.33±0.031.00.36
 Oesophagus dilation no51/326210.31±0.070.37±0.071.3 (0.8 to 2.0)
Manometry before treatment
 LOS pressure ≤10 mm Hg10/28230.29±0.180.29±0.181.00.91
 LOS pressure >10 mm Hg272/282880.25±0.280.32±0.030.9 (0.3 to 3.0)
Obliteration balloon's waist
 Yes217/327450.16±0.030.19±0.031.0<0.001
 No110/327620.48±0.050.60±0.053.6 (2.4 to 5.3)
Balloon diameter
 Consistent (40 mm)212700.24±0.030.32±0.041.00.63
 Incremental (30–35–40 mm)63160.27±0.070.37±0.091.1 (0.6 to 1.9)
 Other61250.39±0.060.42±0.071.3 (0.8 to 2.0)
Manometry 3 months after treatment
 LOS pressure ≤10 mm Hg82/251150.17±0.040.19±0.051.00.03
 LOS pressure >10 mm Hg169/251610.25±0.030.33±0.041.9 (1.1 to 3.3)
Total3361110.28±0.030.34±0.03
  • HR were calculated in univariate Cox regression analysis.

  • LOS, lower oesophageal sphincter.